Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

The Ailliance Post-Market Clinical Study

The purpose of this clinical study is to collect performance and safety data for post-market Medtronic devices indicated for cranial and/or spinal indication(s). Subjects are enrolled and followed postoperatively to 24 months. The Ailliance clinical study is intended to collect data congruous with routine clinical care practices.

Participants needed: 1,000
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Medtronic Spinal and BiologicsUpdated: Jun 30, 2026Locations: 28
Eligibility criteria

Subject provides written informed consent per institution and/or geographical re... [+3]

Subject is currently enrolled or plans to enroll in concurrent drug/device/biolo... [+3]

Status: Not yet recruiting

MDT-0123 Japan Study

The purpose of this clinical trial is to compare the efficacy and safety of this investigational device with autologous iliac bone graft (ICBG) in patients who are deemed to require bone fusion through spinal fixation at two levels (ALIF or OLIF) due to disc degeneration or spinal deformity in the lumbosacral spine (L2-S1) for intervertebral support and correction with the aim of stabilizing the spine.

Participants needed: 140
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Medtronic Spinal and BiologicsUpdated: Feb 17, 2026Locations: 13
Eligibility criteria

Image findings of symptomatic degenerative lesions from L2 to S1(MRI or myelogra... [+1]

Has undergone previous spinal surgery at the intervertebral level in question or... [+26]

Status: Recruiting

A Post Market Surveillance on INFUSE Bone Graft

This study aims to evaluate the safety and effectiveness of INFUSE™ Bone Graft in the real-world setting in Korea.

Participants needed: 600
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Medtronic Spinal and BiologicsUpdated: Mar 20, 2025Locations: 1
Eligibility criteria

Has degenerative disc disease and is indicated for lumbar interbody spine fusion... [+4]

Has a known hypersensitivity to recombinant human Bone Morphogenetic Protein-2,... [+15]